216
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Randomized double-blinded controlled trial on the effect of synbiotic supplementation on IL-17/IL-23 pathway and disease activity in patients with axial spondyloarthritis

, , ORCID Icon, & ORCID Icon
Pages 43-51 | Received 01 Mar 2022, Accepted 05 Aug 2022, Published online: 18 Aug 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sareh Hosseini, Mohammad Sadegh Soltani-Zangbar, Majid Zamani, Yoda Yaghoubi, Reza Rikhtegar Ghiasi, Roza Motavalli, Ali Ghassabi, Rahim Iranzad, Amir Mehdizadeh, Seyed Kazem Shakouri, Alireza Pishgahi & Mehdi Yousefi. (2023) Comparative evaluation of autologous platelet-rich plasma and platelet lysate in patients with knee osteoarthritis. Growth Factors 41:3, pages 165-177.
Read now

Articles from other publishers (2)

Alireza Khabbazi, Masoud Ahangari Maleki, Mohammad Sadegh Soltani-Zangbar, Mehdi Yousefi & Aida Malek Mahdavi. (2022) Effects of synbiotic supplementation on regulatory T cells’ response in patients with axial spondyloarthritis: a randomized double-masked placebo-controlled trial. Food & Function 13:24, pages 12733-12741.
Crossref
Matthew L. Stoll. (2022) Therapeutic alteration of the microbiota in rheumatic diseases: Hype or potential?. Best Practice & Research Clinical Rheumatology 36:4, pages 101806.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.